Literature DB >> 27112135

Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study.

Naoki Sakuyama1,2, Motohiro Kojima3, Shingo Kawano1,2, Tetsuo Akimoto2, Norio Saito1, Masaaki Ito1, Atsushi Ochiai3.   

Abstract

Pathological studies on the different histological effects between neoadjuvant chemotherapy (NAC) and preoperative chemoradiation therapy (preoperative CRT) have not been performed. The purpose of this study is to elucidate the histological differences in tissue received from NAC and preoperative CRT for rectal cancer to evaluate whether a pathological assessment method used after CRT can be applied for NAC. One hundred and thirty-eight patients were enrolled in this study; 88 patients underwent their operations after preoperative CRT or NAC, and 50 patients underwent surgery only. Residual tumor area was measured using morphometry software and we compared the stromal component of myofibroblasts, immune cells, and vasculature to elucidate the difference of therapeutic effect between them. The grade of reduction after preoperative CRT was more prominent than that seen in NAC. Also, ypT downstaging was more prominent in preoperative CRT than in NAC, and ypN downstaging was more frequent in NAC than in preoperative CRT. Preoperative CRT showed more marked myofibroblasts and fewer immune cells than did NAC, which indicates different effects on the cancer microenvironment. Our histological results suggest different effects between NAC and preoperative CRT on tumor tissue. The best assessment method available for a variable therapeutic protocol should be further investigated.
© 2016 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  neoadjuvant chemotherapy; preoperative chemoradiotherapy; rectal cancer

Mesh:

Year:  2016        PMID: 27112135     DOI: 10.1111/pin.12409

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

Review 1.  Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI.

Authors:  Marc J Gollub; Chandana Lall; Neeraj Lalwani; Michael H Rosenthal
Journal:  Abdom Radiol (NY)       Date:  2019-11

Review 2.  Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples.

Authors:  Seth I Felder; Sebastian Feuerlein; Arthur Parsee; Iman Imanirad; Julian Sanchez; Sophie Dessureault; Richard Kim; Sarah Hoffe; Jessica Frakes; James Costello
Journal:  Abdom Radiol (NY)       Date:  2020-10-28

3.  Clinicopathologic determinants of pathologic treatment response in neoadjuvant treated rectal adenocarcinoma.

Authors:  Iván González; Philip S Bauer; William C Chapman; Zahra Alipour; Rehan Rais; Jingxia Liu; Deyali Chatterjee
Journal:  Ann Diagn Pathol       Date:  2019-12-14       Impact factor: 2.090

Review 4.  Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Authors:  Huaqin Lin; Lei Wang; Xiaohong Zhong; Xueqing Zhang; Lingdong Shao; Junxin Wu
Journal:  World J Surg Oncol       Date:  2021-05-05       Impact factor: 2.754

5.  Temporary Diverting Stoma Improves Recovery of Anastomotic Leakage after Anterior Resection for Rectal Cancer.

Authors:  Yuchen Wu; Hongtu Zheng; Tianan Guo; Adili Keranmu; Fangqi Liu; Ye Xu
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

6.  Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapy.

Authors:  Naoki Sakuyama; Motohiro Kojima; Shingo Kawano; Yoko Matsuda; Mari Mino-Kenudson; Atsushi Ochiai; Masaaki Ito
Journal:  Cancer Sci       Date:  2018-03       Impact factor: 6.716

7.  The Prognostic Importance of CD20+ B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets.

Authors:  Sofia Edin; Tuomas Kaprio; Jaana Hagström; Pär Larsson; Harri Mustonen; Camilla Böckelman; Karin Strigård; Ulf Gunnarsson; Caj Haglund; Richard Palmqvist
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

8.  Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer.

Authors:  Ken Imaizumi; Toshihiro Suzuki; Motohiro Kojima; Manami Shimomura; Naoki Sakuyama; Yuichiro Tsukada; Takeshi Sasaki; Yuji Nishizawa; Akinobu Taketomi; Masaaki Ito; Tetsuya Nakatsura
Journal:  Cancer Sci       Date:  2019-12-18       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.